BioNTech

Pfizer Partner Looking to Mix mRNA Vaccine with Chinese Products

China’s state-run Global Times on Thursday reported that BioNTech, the German company that partnered with American company Pfizer to produce its coronavirus vaccine, is “considering to evaluate” mixing its mRNA product with the vaccine manufactured by China’s Fosun Pharma.

A health worker prepares doses of the Pfizer-BioNTech and Janssen vaccine against COVID-19 in the medical centre of Allariz before beginning an in-house vaccination campaign for the elderly in rural areas on April 30, 2021. (Photo by MIGUEL RIOPA / AFP) (Photo by MIGUEL RIOPA/AFP via Getty Images)

FDA Approves Pfizer’s Coronavirus Vaccine

The Food and Drug Administration (FDA) on Friday night approved the first coronavirus vaccine for emergency use in the United States, several media outlets reported, clearing the way for U.S. officials to begin vaccinating millions of Americans as early as next week.

Pfizer has said it will be able to supply up to 25 million doses before the end of the year, and 100 million total vaccines by March.Credit...Justin Tallis/Agence France-Presse — Getty Images